Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma

Thomas T DeLeon1, Daniel H Ahn1, James M Bogenberger1

  • 1Division of Hematology Oncology, Department of Medicine, Mayo Clinic, Scottsdale, AZ 85259, USA.

Insights

Hepatobiliary cancers cause many deaths globally, with limited treatments. Emerging biomarkers and therapies, like nivolumab for hepatocellular carcinoma and FGFR2/IDH1 targets for cholangiocarcinoma, offer new hope.

Area of Science:

  • Oncology
  • Gastroenterology
  • Cancer Research

Background:

  • Hepatobiliary cancers represent a significant global health burden, ranking as the second leading cause of cancer-related mortality worldwide.
  • There is a critical unmet need for effective systemic therapies in advanced and metastatic stages of these malignancies.
  • Current treatment options for hepatobiliary cancers are limited, highlighting the necessity for novel therapeutic strategies.

Purpose of the Study:

  • To review emerging therapeutic biomarkers and innovative treatment concepts for hepatobiliary cancers.
  • To highlight promising advancements in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
  • To identify additional biomarkers requiring further investigation in the broader category of hepatobiliary cancers.

Main Methods:

  • Literature review of recent advancements in systemic therapy for hepatobiliary cancers.
  • Analysis of approved and investigational therapies targeting specific molecular pathways and immune checkpoints.
  • Identification and categorization of potential biomarkers for therapeutic targeting.

Main Results:

  • Nivolumab has shown promise and received US FDA approval for hepatocellular carcinoma.
  • Intrahepatic cholangiocarcinoma is seeing advancements with therapies targeting FGFR2, IDH1, and immune checkpoint inhibitors.
  • Several biomarkers including FGF19, ERRFI1, TERT, BAP1, BRAF, CDKN2A, tumor mutational burden, and ERBB2 (HER2/neu) warrant further exploration.

Conclusions:

  • Emerging biomarkers and novel therapeutic strategies hold significant promise for improving outcomes in hepatobiliary cancers.
  • Targeted therapies and immunotherapies represent key areas of development for these challenging diseases.
  • Continued research into novel agents and biomarkers is crucial to address the unmet needs in advanced hepatobiliary cancers.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
451
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
469
Nerve Supply of the GI Tract01:27

Nerve Supply of the GI Tract

The neuronal supply to the gastrointestinal (GI) tract is essential for regulating various functions, including digestion, absorption, and movement of food. This intricate network of nerves is known as the enteric nervous system (ENS), often referred to as the "second brain" of the body.
The enteric nervous system consists of two major plexuses: the myenteric plexus (Auerbach's plexus) and the submucosal plexus (Meissner's plexus). These plexuses are located within the layers of...
3.7K